An analysis of the ethical concerns regarding drug testing in corporate companies

Because practitioners of the statistical analysis often address particular applied decision problems, methods developments is consequently motivated by the search to a better decision making under uncertainties. Decision making process under uncertainty is largely based on application of statistical data analysis for probabilistic risk assessment of your decision. Managers need to understand variation for two key reasons.

An analysis of the ethical concerns regarding drug testing in corporate companies

Ethical Issues in Pharmaceutical Sales Posted on by Richard Meyer In the health care industry, pharmaceutical sales representatives play an important role.

But for years, pharmaceutical sales reps were seen less as educators and health care facilitators and more as salespeople, more concerned about meeting sales goals than ethical considerations.

Global Health Overview — Global Issues

From giving doctors elaborate gifts and experiences to recommending off-label uses for drugs, the pharmaceutical industry had a reputation for playing fast and loose with ethics in the name of the sale — but that is changing. Perhaps the rep would offer prime seats at a baseball or football game in exchange for a meeting.

An analysis of the ethical concerns regarding drug testing in corporate companies

Regardless of the offer, the idea was the same: Pharmaceutical salespeople would do whatever it took to entice doctors to listen to them and choose their products over others. The competition inherent in the pharmaceutical industry — companies spend millions developing, researching and marketing their products — puts undue pressure on sales and marketing teams to make sales.

This amounted to essential bribes to promote products. The Office of the Inspector General OIG and the Pharmaceutical Researchers and Manufacturers of America PHRMA developed these guidelines to create a stricter ethical environment and maintain the integrity of both physicians and the pharmaceutical industry when it comes to the sale and prescribing of drugs.

In short, pharmaceutical companies are now being held to anti-kickback laws, prohibiting them from offering anything of significant value in exchange for purchasing, referring or otherwise supporting a specific drug.

Implications for Sales Forces Taking away the ability to sway doctors toward one product or another via perks begs the question of how drug reps can promote their products and protect the bottom line, especially in an era of distrust among doctors. Keeping ethical considerations in mind, some companies have shifted their sales activities to more educational initiatives, focusing on offering continuing education seminars that highlight their products and building specialized sales forces with experience in particular types of medicine, so that reps can become a useful resource to physicians, offering up-to-date information that doctors may not already know.

The new ethical guidelines for pharmaceutical reps have made significant progress in creating a more ethical and effective industry, but some reps are still skirting the law and engaging in practices like off-label marketing to get face time with physicians.

Image by Baitong from freedigitalphotos. Medical writer Allie Abbot covers developments in the health care industry for a news blog. Its interesting to see the US employ this level of governance to the pharmaceutical business model. Our organizational goal has been to moderate ourselves and hold our peers to account while demonstrating a dedication to not only our guidelines but the spirit in which they were written.

An analysis of the ethical concerns regarding drug testing in corporate companies

Our code can be found here for comparison:Big Data: A Twenty-First Century Arms Race - Free download as PDF File .pdf), Text File .txt) or read online for free. We are living in a world awash in data.

Accelerated interconnectivity, driven by the proliferation of internet-connected devices, has led to an explosion of data—big data. A race is now underway to develop new technologies and implement innovative methods that can handle. Arnold S. Trebach, JD, PhD, a professor at American University, and Kevin B.

Zeese, an attorney who had directed the National Organization for the Reform of Marijuana Laws in the early s, founded The Drug Policy Foundation (DPF). Type or paste a DOI name into the text box. Click Go. Your browser will take you to a Web page (URL) associated with that DOI name.

Send questions or comments to doi. Get the latest health news, diet & fitness information, medical research, health care trends and health issues that affect you and your family on A whistleblower (also written as whistle-blower or whistle blower) is a person who exposes any kind of information or activity that is deemed illegal, unethical, or not correct within an organization that is either private or public.

The information of alleged wrongdoing can be classified in many ways: violation of company policy/rules, law, regulation, or threat to public interest/national. Ethical Aspects of Drug Testing The federal government and many companies have adopted policies regarding the use of drugs, as well as instituting a variety of drug screening, control, and rehabilitation programs.

Resolve a DOI Name